Stifel Financial’s Array Biopharma Inc ARRY Stock Holding History

Stifel Financial’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,214	Closed	-$1.4M	–	3052
2019 Q2	$1.4M	Sell	30,214 -24,645	-45%	-$692K	﹤0.01%	1580
2019 Q1	$1.33M	Buy	54,859 +10,810	+25%	+$225K	﹤0.01%	1482
2018 Q4	$622K	Buy	+44,049	New	+$668K	﹤0.01%	1825
2017 Q1	–	Sell	-19,145	Closed	-$169K	–	2642
2016 Q4	$169K	Sell	19,145 -11,020	-37%	-$81.1K	﹤0.01%	2296
2016 Q3	$205K	Buy	30,165 +9,745	+48%	+$37.7K	﹤0.01%	2170
2016 Q2	$73K	Buy	20,420 +1,205	+6%	+$3.93K	﹤0.01%	2405
2016 Q1	$56K	Buy	19,215 +75	+0.4%	+$225	﹤0.01%	2159
2015 Q4	$81K	Buy	+19,140	New	+$87.4K	﹤0.01%	2248

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Stifel Financial's ARRY Position: Q3 2019 in Review

Stifel Financial sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 30,214 shares — an estimated $1.4M sold.

Stifel Financial first reported a position in ARRY in Q4 2015 and held it in 8 quarters. The position peaked at $1.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Stifel Financial reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Stifel Financial sold 30,214 Array Biopharma Inc shares in Q3 2019, an estimated $1.4M.
Stifel Financial first reported a position in Array Biopharma Inc in Q4 2015 and held it in 8 quarters.
Stifel Financial's Array Biopharma Inc position peaked at $1.4M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.